NCT01722708View on ClinicalTrials.gov

Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies

NARecruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

November 1, 2012

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Abnormal Vaginal FloraClindamycin Vs MetronidazoleHigh Risk Pregnancies for Preterm Labor
Interventions
DRUG

Clindamycin

Oral clindamycin 300 Milligrams\*2/Day for a week

DRUG

Metronidazole

Oral metronidazole 500 Milligrams\*2/Day for a week

Trial Locations (2)

Unknown

RECRUITING

Departement of obstetric and gynecology, HaEmek medical center, Afula

RECRUITING

Departement of obstetric and gynecology, Poriya Medical Center, Tiberias

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER